Stock Taper
Latest 13F filing data - Q2 2026
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
Waters Corporation | WAT | 14.04K | $5.27M |
argenx SE | ARGX | 17.71K | $16.43M |
Quest Diagnostics Incorporated | DGX | 43.2K | $9.16M |
Elevance Health Inc. | ELV | 53.96K | $20.87M |
Intuitive Surgical, Inc. | ISRG | 70.14K | $27.89M |
Natera, Inc. | NTRA | 79.5K | $21.58M |
Thermo Fisher Scientific Inc. | TMO | 89.39K | $44.82M |
Humana Inc. | HUM | 114.5K | $45.48M |
Ionis Pharmaceuticals, Inc. | IONS | 116.76K | $9.26M |
Krystal Biotech, Inc. | KRYS | 128.97K | $47.94M |
Guardant Health, Inc. | GH | 147.85K | $22.18M |
Danaher Corporation | DHR | 150.63K | $28.69M |
Hemab Therapeutics Holdings, Inc. Common Stock | COAG | 160K | $5.88M |
Repligen Corporation | RGEN | 177.1K | $24.16M |
Kiniksa Pharmaceuticals International, plc | KNSA | 183.82K | $11.76M |
Oruka Therapeutics, Inc. | ORKA | 278.16K | $26.47M |
Kardigan, Inc. | KARD | 300K | $7.16M |
uniQure N.V. | QURE | 301.65K | $13.89M |
Neurocrine Biosciences, Inc. | NBIX | 336.17K | $56.66M |
Kymera Therapeutics, Inc. | KYMR | 378.16K | $43.36M |